Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
QT Imaging Holdings, Inc. (QTI)
USD3.63
+0.01 (+0.14%)
US NASDAQ Healthcare Medical - Devices
Address
Three Hamilton Landing 94949
Novato, US
Novato, US
CEO
Raluca Dinu
Website
qtimaging.com
IPO
2024-03-05
CIK 1844505 ISIN US7469623075
Also trades on
NASDAQ Global Market · QTI (USD)
New York Stock Exchange · GIA (USD)
New York Stock Exchange · GIA-UN (USD)
New York Stock Exchange · GIA-WT (USD)
Description
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.63
+0.01 (+0.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
50.7K
Beta
-0.08
Float Shares
17.98M
Free Float %
66.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -16.73% | -10.99% | -7.74% | +12.66% | +5.16% | +3.61% | +680.25% | +368.15% | +368.15% | +368.15% | +368.15% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3.63
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.98
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+287.9% ★ Q1'26: +133.3% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-183.1% Q1'26: +37.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-58.4% Q1'26: -56.2% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-23.5% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-361.6% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-47.6% ★ Q1'26: -49.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.18× Q1'26: -0.62× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
18.93M
est: 18.35M (+3.1%)
|
38.65M
38.20M – 39.10M
+110.6% YoY
|
62.10M
54.90M – 69.30M
+60.7% YoY
|
74.43M
68.78M – 80.08M
+19.9% YoY
|
| EBITDA |
-4.44M
est: -7.74M (+42.7%)
|
-16.31M
-16.50M – -16.12M
-110.6% YoY
|
-26.21M
-29.25M – -23.17M
-60.7% YoY
|
-31.41M
-33.80M – -29.03M
-19.9% YoY
|
| EBIT |
-4.44M
est: -7.92M (+44.0%)
|
-16.68M
-16.87M – -16.48M
-110.6% YoY
|
-26.80M
-29.90M – -23.69M
-60.7% YoY
|
-32.12M
-34.55M – -29.68M
-19.9% YoY
|
| Net Income |
-21.08M
est: -16.92M (-24.6%)
|
-1.15M
-1.27M – -1.04M
+93.2% YoY
|
3.35M
3.02M – 3.68M
+390.9% YoY
|
6.08M
5.48M – 6.68M
+81.3% YoY
|
| SGA |
9.09M
est: 375.95M (-97.6%)
|
791.86M
782.64M – 801.08M
+110.6% YoY
|
1.27B
1.12B – 1.42B
+60.7% YoY
|
1.52B
1.41B – 1.64B
+19.9% YoY
|
| EPS |
-2.01
est: -1.62 (-24.5%)
|
-0.11
-0.12 – -0.10
+93.2% YoY
|
0.32
0.29 – 0.35
+390.9% YoY
|
0.58
0.52 – 0.64
+81.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-5.82M
OE per share TTM
-0.37
Owner's Yield
-6.67%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
20.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
20
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dr. Avi S. Katz | 6.00M | 28.00% | 53.2K | 6.00M | 53.2K | 11.00 | IN | — | 2024-07-03 | ↗ |
| 2 | GigAcquisitions5, LLC | 6.00M | 28.00% | — | 5.95M | — | 11.00 | PN | — | 2024-07-03 | ↗ |
| 3 | John C. Klock, Jr. | 2.88M | 13.40% | — | 2.88M | — | 2.88M | PN | — | 2024-03-18 | ↗ |
| 4 | Cynthia Paul | 1.92M | 9.00% | 1.92M | — | 1.92M | — | HC, IN | Delaware | 2024-11-14 | ↗ |
| 5 | Lynrock Lake LP | 1.92M | 9.00% | 1.92M | — | 1.92M | — | IA, PN | Delaware | 2024-11-14 | ↗ |
| 6 | Lynrock Lake Partners LLC | 1.92M | 9.00% | 1.92M | — | 1.92M | — | HC, OO | Delaware | 2024-11-14 | ↗ |
| 7 | Highbridge Capital Management, LLC | 1.60M | 5.43% | — | 1.60M | — | — | IA, OO | State of Delaware | 2021-12-23 | ↗ |
| 8 | Notes). | 1.60M | 5.42% | — | 1.60M | — | 1.60M | IA | DELAWARE | 2022-02-11 | ↗ |
| 9 | D. E. Shaw & Co., L.L.C | 1.56M | 5.30% | — | 1.56M | — | — | OO | Delaware | 2022-02-22 | ↗ |
| 10 | D. E. Shaw & Co., L.P. | 1.56M | 5.30% | — | 1.56M | — | — | IA, PN | Delaware | 2022-02-22 | ↗ |
| 11 | David E. Shaw | 1.56M | 5.30% | — | 1.56M | — | — | IN | United States | 2022-02-22 | ↗ |
| 12 | D. E. Shaw Valence Portfolios, L.L.C. | 1.56M | 5.30% | — | 1.56M | — | — | OO | Delaware | 2022-02-22 | ↗ |
| 13 | Polar Asset Management Partners Inc. | 1.55M | 14.66% | 1.55M | — | 1.55M | — | IA | Ontario, Canada | 2023-02-10 | ↗ |
| 14 | Israel A. Englander | 1.48M | 5.00% | — | 1.48M | — | 1.48M | IN | — | 2022-07-06 | ↗ |
| 15 | Millennium Group Management LLC | 1.48M | 5.00% | — | 1.48M | — | 1.48M | OO | — | 2022-07-06 | ↗ |
| 16 | Millennium Management LLC | 1.48M | 5.00% | — | 1.48M | — | 1.48M | OO | — | 2022-07-06 | ↗ |
| 17 | Meteora Capital, LLC | 832.8K | 9.62% | — | 832.8K | — | — | IA | Delaware | 2024-02-14 | ↗ |
| 18 | Vik Mittal | 832.8K | 9.62% | — | 832.8K | — | — | IN | United States | 2024-02-14 | ↗ |
| 19 | Shaolin Capital Management LLC | 354.9K | 7.36% | 354.9K | — | 354.9K | — | IA | Miami | 2023-02-14 | ↗ |
| 20 | Space Summit Capital LLC | — | 0.00% | — | — | — | — | IA | — | 2022-02-02 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 113.8K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 506.9K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 2.6K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 7.2K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 529.79 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.23M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.7K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.5K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 590.71 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 65.14 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
2.35M
Shares disposed
—
Cash buys
4.00
Cash sales
—
Net activity
+2,354,787
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Weiner Zeev | Director | A-Award | A | Common Stock | 3,500 | 0.00 | — | 55,093 | D | ↗ |
| 2026-03-20 | Taylor Ross | Director | A-Award | A | Common Stock | 3,500 | 0.00 | — | 60,578 | D | ↗ |
| 2026-03-20 | Katz Avi S | Director / Officer | A-Award | A | Common Stock | 3,500 | 0.00 | — | 416,952 | D | ↗ |
| 2026-03-20 | KLOCK JOHN C JR | Director / 10% Owner | A-Award | A | Common Stock | 3,500 | 0.00 | — | 3,500 | D | ↗ |
| 2026-03-20 | Jennings Jay Walter | Officer | A-Award | A | Common Stock | 2,800 | 0.00 | — | 2,800 | D | ↗ |
| 2026-03-20 | GREENE JAMES S | Director | A-Award | A | Common Stock | 3,500 | 0.00 | — | 3,500 | D | ↗ |
| 2026-03-20 | Dinu Raluca | Director / Officer | A-Award | A | Common Stock | 3,500 | 0.00 | — | 392,845 | D | ↗ |
| 2026-03-20 | DICKSON DANIEL H | Director | A-Award | A | Common Stock | 3,500 | 0.00 | — | 32,039 | D | ↗ |
| 2026-03-17 | Weiner Zeev | Director | M-Exempt | D | Stock Option (right to buy) | 14,166 | 2.00 | 28.3K | 0 | D | ↗ |
| 2025-08-11 | KLOCK JOHN C JR | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 25,000 | 1.90 | 47.5K | 25,000 | D | ↗ |
| 2025-04-09 | Katz Avi S | Director / Officer | P-Purchase | A | Common Stock | 392,464 | 0.64 | 250.0K | 1,168,035 | D | ↗ |
| 2025-04-09 | Dinu Raluca | Director / Officer | P-Purchase | A | Common Stock | 392,465 | 0.64 | 250.0K | 1,168,035 | D | ↗ |
| 2025-03-21 | Katz Avi S | Director / Officer | P-Purchase | D | Common Stock | 2,671,232 | 0.58 | 1.56M | 0 | I | ↗ |
| 2025-03-21 | Dinu Raluca | Director / Officer | P-Purchase | A | Subscription Warrants (right to buy) | 75,435 | 0.67 | 50.7K | 546,325 | D | ↗ |
| 2024-11-12 | Weiner Zeev | Director | P-Purchase | A | Common Stock | 85,616 | 0.58 | 50.0K | 85,616 | D | ↗ |
| 2024-11-12 | Taylor Ross | Director | P-Purchase | A | Subscription Warrant (right to buy) | 171,232 | 0.67 | 115.1K | 171,232 | D | ↗ |
| 2024-11-12 | Katz Avi S | Director / Officer | P-Purchase | A | Subscription Warrants (right to buy) | 470,890 | 0.67 | 316.4K | 470,890 | D | ↗ |
| 2024-11-12 | GREENE JAMES S | Director | P-Purchase | A | Subscription Warrant (right to buy) | 428,082 | 0.67 | 287.7K | 428,082 | I | ↗ |
| 2024-11-12 | Dinu Raluca | Director / Officer | P-Purchase | A | Subscription Warrants (right to buy) | 470,890 | 0.67 | 316.4K | 470,890 | D | ↗ |
| 2024-11-12 | DICKSON DANIEL H | Director | P-Purchase | A | Common Stock | 85,616 | 0.58 | 50.0K | 85,616 | D | ↗ |
| 2024-09-04 | Katz Avi S | Director / Officer | J-Other | A | Common Stock | 161,954 | 0.00 | — | 187,070 | — | ↗ |
| 2024-09-04 | Dinu Raluca | Director / Officer | J-Other | A | Common Stock | 161,954 | 0.00 | — | 187,069 | — | ↗ |
| 2024-07-05 | Katz Avi S | Director / Officer / 10% Owner | J-Other | D | Private Warrants | 105,773 | 2.30 | 243.3K | 0 | — | ↗ |
| 2024-07-03 | Weiner Zeev | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 0.75 | 29.9K | 40,000 | — | ↗ |
| 2024-07-03 | Taylor Ross | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 0.75 | 29.9K | 40,000 | — | ↗ |
| 2024-07-03 | Katz Avi S | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 40,000 | 0.75 | 29.9K | 40,000 | — | ↗ |
| 2024-07-03 | KLOCK JOHN C JR | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 40,000 | 0.75 | 29.9K | 40,000 | — | ↗ |
| 2024-07-03 | GREENE JAMES S | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 0.75 | 29.9K | 40,000 | — | ↗ |
| 2024-07-03 | Dinu Raluca | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 550,000 | 0.75 | 411.4K | 550,000 | — | ↗ |
| 2024-07-03 | Dickson Daniel | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 0.75 | 29.9K | 40,000 | — | ↗ |
| 2024-07-03 | Budagov Stas | Officer | A-Award | A | Employee Stock Option (right to buy) | 325,000 | 0.75 | 243.1K | 325,000 | — | ↗ |
| 2024-06-27 | Katz Avi S | Director / Officer / 10% Owner | J-Other | D | Private Warrants | 783,591 | 2.30 | 1.80M | 105,773 | — | ↗ |
| 2024-06-27 | Dinu Raluca | Director / Officer | J-Other | D | Common Stock | 26,592 | 0.00 | — | 26,592 | — | ↗ |
| 2024-03-21 | GREENE JAMES S | Director | — | I | Common Stock | 0 | 0.00 | — | 200,000 | — | ↗ |
| 2024-03-18 | McMorrow Gerald | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | Weiner Zeev | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | Weightman Walter Bradford | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | Taylor Ross | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | ROGGE KAREN M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | McMorrow Gerald | Director | A-Award | A | Common Stock | 5,904 | 3.53 | 20.8K | 5,904 | — | ↗ |
| 2024-03-04 | Katz Avi S | Director / Officer / 10% Owner | M-Exempt | A | Private Warrants | 94,364 | 11.50 | 1.09M | 94,364 | — | ↗ |
| 2024-03-04 | KLOCK JOHN C JR | Director / Officer | A-Award | A | Common Stock | 2,881,140 | 3.53 | 10.17M | 2,881,140 | — | ↗ |
| 2024-03-04 | Horowitz Raanan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | HAYES DOROTHY D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | Dickson Daniel | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-04 | Budagov Stas | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-04 | MAKHIJA SHARMILA | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-23 | Katz Avi S | Director / Officer / 10% Owner | A-Award | A | Common Stock | 795,000 | 10.00 | 7.95M | 6,530,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-443.7K
Shares Outstanding
27.13M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Raluca Dinu | Chief Executive Officer & Director | 635.9K | — |
| Jay W. Jennings | Chief Financial Officer | 344.4K | male |
| Bilal Malik | Chief Science Officer | — | — |
| Satrajit Misra | Chief Commercial Officer | — | male |
| Steve Choate | Chief Operating Officer | — | male |
| Nasser C. Pirshafiey | Chief Product Officer | — | male |
| Elaine Iuanow | Chief Medical Officer | — | — |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for QTI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
